Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-010903
Filing Date
2008-02-15
Accepted
2008-02-15 13:01:13
Documents
2
Period of Report
2007-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2130
2 POA DOCUMENT poa.txt EX-24.3_225564 3163
  Complete submission text file 0001209191-08-010903.txt   7163
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RHEIN BIOTECH GMBH (DYNAVAX EUROPE) EICHSFELDER STR. 11 DUSSELDORF 2M 40595
Business Address 49 0 211 7 58 45 0
JANOWICZ ZBIGNIEW (Reporting) CIK: 0001427375 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50577 | Film No.: 08621830